Axsome Therapeutics (AXSM) Return on Equity [ROE] (2016 - 2026)
Axsome Therapeutics (AXSM) recorded Return on Equity [ROE] of -166.73% in Q3 2026, up 145.92 percentage points from -312.65% a year earlier and up 111.29 percentage points from the prior quarter.
Axsome Therapeutics (AXSM) Return on Equity [ROE] (2016 - 2026) Analysis & Trends
For FY2025, Axsome Therapeutics reported Return on Equity [ROE] of -252.11%, down 20.48 percentage points from FY2024.
- Annual Return on Equity [ROE] has a five-year change of -182.58 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -231.63% in FY2024 (-72.42 pp), -159.21% in FY2023 (+139.76 pp), -298.97% in FY2022 (-97.45 pp) and -201.51% in FY2021 (-131.97 pp).
- The Q3 2026 figure is the highest quarterly Return on Equity [ROE] since Q4 2023.
- On a year-over-year basis, Return on Equity [ROE] has increased for five consecutive quarters, with an average year-over-year change of -10.75 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 908.52 percentage points in Q2 2023, against a drop of 868.90 percentage points in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at -278.02% (Q2 2026), -263.58% (Q1 2026) and -226.11% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Axsome Therapeutics | 7.41 Bn | 6.15 Bn | 241.89 Mn | -166.73% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -166.73% |
| Jun 30, 2026 | -278.02% |
| Mar 31, 2026 | -263.58% |
| Dec 31, 2025 | -226.11% |
| Sep 30, 2025 | -312.65% |
| Jun 30, 2025 | -390.97% |
| Mar 31, 2025 | -504.94% |
| Dec 31, 2024 | -383.18% |
| Sep 30, 2024 | -317.69% |
| Jun 30, 2024 | -249.92% |
| Mar 31, 2024 | -176.91% |
| Dec 31, 2023 | -103.90% |
| Sep 30, 2023 | -73.62% |
| Jun 30, 2023 | -94.45% |
| Mar 31, 2023 | -143.42% |
| Dec 31, 2022 | -140.22% |
| Sep 30, 2022 | -185.29% |
| Jun 30, 2022 | -1,002.97% |
| Mar 31, 2022 | -928.32% |
| Dec 31, 2021 | -446.98% |
Axsome Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AXSM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "AXSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AXSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();